Non-invasive algorithms could outperform HVPG in selecting candidates for non-selective beta-blockers in cirrhosis

IF 26.8 1区医学 Q1 GASTROENTEROLOGY & HEPATOLOGY

Journal of Hepatology Pub Date : 2024-11-13 DOI:10.1016/j.jhep.2024.11.011

Emma Vanderschueren

引用次数: 0

Abstract

Section snippets

Author contributions

Conceptualization, data curation, formal analysis and writing of the manuscript were performed by EV and WL.

Financial support

None.

Declaration of Competing Interest

WL serves as a consultant for Cook Medical, MRM Health, and CSL Behring, and has received speaker’s fees from Boston Scientific. No other conflicts of interest were withheld.

Acknowledgements

We wish to thank Prof. Antonio Colecchia for his assistance in providing additional data from the validation cohort.

查看原文本刊更多论文

在肝硬化患者非选择性β-受体阻滞剂的候选药物选择方面，无创算法优于 HVPG

作者贡献构思、数据整理、正式分析和手稿撰写由 EV 和 WL 完成。财务支持无。竞争利益声明WL 担任 Cook Medical、MRM Health 和 CSL Behring 的顾问，并从波士顿科学公司获得演讲费。没有隐瞒其他利益冲突。感谢 Antonio Colecchia 教授协助提供验证队列的其他数据。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Hepatology 医学-胃肠肝病学

CiteScore

46.10

自引率

4.30%

发文量

2325

审稿时长

30 days

期刊介绍： The Journal of Hepatology is the official publication of the European Association for the Study of the Liver (EASL). It is dedicated to presenting clinical and basic research in the field of hepatology through original papers, reviews, case reports, and letters to the Editor. The Journal is published in English and may consider supplements that pass an editorial review.